Literature DB >> 1997467

Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethylornithine on the growth and the activity of ornithine decarboxylase of colonic carcinoma cells.

S Eggstein1, A Imdahl, M Kohler, M Waibel, E H Farthmann.   

Abstract

Polyamines are essential factors of cell growth and differentiation. Modulation of the cellular polyamine content by 2-difluoromethylornithine (DFMO) inhibiting ornithine decarboxylase (ODC), or by hormones inducing ODC, influences cell growth. Gastrin acts trophically on some colonic carcinomas and their growth is inhibited by gastrin receptor blockers. The mechanism of the trophic action of gastrin on colonic carcinomas is not known. In this study the effect of gastrin, gastrin receptor blockers, epidermal growth factor (EGF) and DFMO on growth and ODC activity of four human colon carcinoma cell lines (SW 403, SW 1116, LS 174 T and Lovo) was investigated. Growth and ODC activity of all cell lines were inhibited by DFMO. Growth of the SW 403 cell line was increased by gastrin and inhibited by the gastrin receptor blocker benzotrypte. The other cell lines did not respond to gastrin and the gastrin receptor blocker. In SW 403 cells ODC activity was increased by gastrin, and was also elevated after treatment with the gastrin receptor blocker. These in vitro results were confirmed by studies on tumours that developed from SW 403 cells in nude mice. Combination of benzotrypte and DFMO did not enhance the antiproliferative effect. EGF increased growth of SW 403 cells, but no induction of ODC activity was measured. LS 174 T cells were not stimulated by EGF. Medium replacement was the strongest stimulus of ODC activity in SW 403 cells already inducing ODC after 3 h. During cell culture ODC activity was high after seeding and decreased continuously with increasing cell density. These data suggest that gastrin induces ODC in gastrin-sensitive colonic carcinoma cells. DFMO appears to be a valuable antiproliferative agent in colonic carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997467     DOI: 10.1007/bf01613194

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  21 in total

1.  Hormonal stimulation of hepatic ornithine decarboxylase.

Authors:  W B Panko; F T Kenney
Journal:  Biochem Biophys Res Commun       Date:  1971-04-16       Impact factor: 3.575

2.  Attenuation of trophic response to gastrin after inhibition of ornithine decarboxylase.

Authors:  E R Seidel; K Tabata; A B Dembinski; L R Johnson
Journal:  Am J Physiol       Date:  1985-07

3.  Gastric mucosal ornithine decarboxylase: localization and stimulation by gastrin.

Authors:  L R Johnson; C C Tseng; U R Tipnis; M K Haddox
Journal:  Am J Physiol       Date:  1988-09

4.  Polyamines in colorectal cancer.

Authors:  A N Kingsnorth; A B Lumsden; H M Wallace
Journal:  Br J Surg       Date:  1984-10       Impact factor: 6.939

Review 5.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

6.  Ornithine decarboxylase inhibitors increase the cellular content of the enzyme: implications for translational regulation.

Authors:  L Persson; S M Oredsson; S Anehus; O Heby
Journal:  Biochem Biophys Res Commun       Date:  1985-08-30       Impact factor: 3.575

7.  Growth of colorectal carcinoma cells: regulation in vitro by gastrin, pentagastrin and the gastrin-receptor antagonist proglumide.

Authors:  A Imdahl; S Eggstein; C Crone; E H Farthmann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

8.  Effects of cholecystokinin on pancreatic ornithine decarboxylase gene expression.

Authors:  S Rosewicz; L D Lewis; R A Liddle; C D Logsdon
Journal:  Am J Physiol       Date:  1988-12

Review 9.  Chemoprevention and chemotherapy by inhibition of ornithine decarboxylase activity and polyamine synthesis: colonic, pancreatic, mammary, and renal carcinomas.

Authors:  R A Malt; A N Kingsnorth; G M Lamuraglia; F Lacaine; J S Ross
Journal:  Adv Enzyme Regul       Date:  1985

10.  Effect of polyamine depletion on c-myc expression in human colon carcinoma cells.

Authors:  P Celano; S B Baylin; F M Giardiello; B D Nelkin; R A Casero
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

View more
  6 in total

Review 1.  Acid suppression and claims of genotoxicity. What have we learned?

Authors:  R A Goodlad
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 2.  Cell proliferation in gastrointestinal mucosa.

Authors:  W M Wong; N A Wright
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

3.  Transforming growth factor-alpha increases tyrosine phosphorylation of microtubule-associated protein kinase in a small intestinal crypt cell line (IEC-6).

Authors:  B L Oliver; R I Sha'afi; J J Hajjar
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

4.  Gastrin and the growth of the gastrointestinal tract.

Authors:  A A Ekundayo; C Y Lee; R A Goodlad
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

5.  Omeprazole inhibits colorectal carcinogenesis induced by azoxymethane in rats.

Authors:  I D Penman; E el-Omar; J R McGregor; K J Hillan; P J O'Dwyer; K E McColl
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

6.  Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome.

Authors:  M Orbuch; D J Venzon; I A Lubensky; H C Weber; F Gibril; R T Jensen
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.